These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1388279)
21. Learning impairment following lesion of the basal nucleus of Meynert in the marmoset: modification by cholinergic drugs. Ridley RM; Murray TK; Johnson JA; Baker HF Brain Res; 1986 Jun; 376(1):108-16. PubMed ID: 3087582 [TBL] [Abstract][Full Text] [Related]
22. Dose-specific effects of scopolamine on canine cognition: impairment of visuospatial memory, but not visuospatial discrimination. Araujo JA; Chan AD; Winka LL; Seymour PA; Milgram NW Psychopharmacology (Berl); 2004 Aug; 175(1):92-8. PubMed ID: 15029470 [TBL] [Abstract][Full Text] [Related]
23. Cholinergic learning deficits in the marmoset produced by scopolamine and ICV hemicholinium. Ridley RM; Barratt NG; Baker HF Psychopharmacology (Berl); 1984; 83(4):340-5. PubMed ID: 6436862 [TBL] [Abstract][Full Text] [Related]
24. The 5-HT 1A receptor antagonist WAY 100635 improves rats performance in different models of amnesia evaluated by the object recognition task. Pitsikas N; Rigamonti AE; Cella SG; Muller EE Brain Res; 2003 Sep; 983(1-2):215-22. PubMed ID: 12914983 [TBL] [Abstract][Full Text] [Related]
29. Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating. Schreiber R; Vivian J; Hedley L; Szczepanski K; Secchi RL; Zuzow M; van Laarhoven S; Moreau JL; Martin JR; Sik A; Blokland A Eur Neuropsychopharmacol; 2007 Mar; 17(4):277-88. PubMed ID: 16989988 [TBL] [Abstract][Full Text] [Related]
30. Attenuation of scopolamine-induced amnesia in mice. Stone WS; Croul CE; Gold PE Psychopharmacology (Berl); 1988; 96(3):417-20. PubMed ID: 3146778 [TBL] [Abstract][Full Text] [Related]
31. (S)-WAY 100135, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Carli M; Luschi R; Samanin R Eur J Pharmacol; 1995 Sep; 283(1-3):133-9. PubMed ID: 7498302 [TBL] [Abstract][Full Text] [Related]
32. Effects of arecoline and pilocarpine on learning ability in marmosets pretreated with hemicholinium-3. Ridley RM; Baker HF; Drewett B Psychopharmacology (Berl); 1987; 91(4):512-4. PubMed ID: 3108931 [TBL] [Abstract][Full Text] [Related]
33. Effect of ondansetron and ICS 205-930 on radiation-induced hypothermia in rats. Kandasamy SB Radiat Res; 1997 Jun; 147(6):741-6. PubMed ID: 9189174 [TBL] [Abstract][Full Text] [Related]
35. Effects of cholinergic drugs on scopolamine-induced memory impairment in rhesus monkeys. Hironaka N; Ando K Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):103-8. PubMed ID: 8905798 [TBL] [Abstract][Full Text] [Related]
36. Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus). Muggleton NG; Bowditch AP; Crofts HS; Scott EA; Pearce PC Psychopharmacology (Berl); 2003 Mar; 166(3):212-20. PubMed ID: 12589520 [TBL] [Abstract][Full Text] [Related]
37. Alleviation of scopolamine amnesia by different retrieval enhancing treatments. Quartermain D; Leo P Pharmacol Biochem Behav; 1988 Aug; 30(4):1093-6. PubMed ID: 3227033 [TBL] [Abstract][Full Text] [Related]
38. Strain-dependent effects on acquisition and reversal of visual and spatial tasks in a rat touchscreen battery of cognition. Kumar G; Talpos J; Steckler T Physiol Behav; 2015 May; 144():26-36. PubMed ID: 25744936 [TBL] [Abstract][Full Text] [Related]
39. Effects of a neurotensin analogue (PD149163) and antagonist (SR142948A) on the scopolamine-induced deficits in a novel object discrimination task. Azmi N; Norman C; Spicer CH; Bennett GW Behav Pharmacol; 2006 Jun; 17(4):357-62. PubMed ID: 16914954 [TBL] [Abstract][Full Text] [Related]
40. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate). Tottori K; Nakai M; Uwahodo Y; Miwa T; Yamada S; Oshiro Y; Kikuchi T; Altar CA J Pharmacol Exp Ther; 2002 Apr; 301(1):249-57. PubMed ID: 11907181 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]